annual SGA:
$0.00-$103.47M(-100.00%)Summary
- As of today (September 14, 2025), AKBA annual SGA is $0.00, with the most recent change of -$103.47 million (-100.00%) on December 31, 2024.
- During the last 3 years, AKBA annual SGA has fallen by -$177.63 million (-100.00%).
- AKBA annual SGA is now -100.00% below its all-time high of $177.63 million, reached on December 31, 2021.
Performance
AKBA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$26.44M(-100.00%)Summary
- As of today (September 14, 2025), AKBA quarterly SGA is $0.00, with the most recent change of -$26.44 million (-100.00%) on June 1, 2025.
- Over the past year, AKBA quarterly SGA has dropped by -$27.68 million (-100.00%).
- AKBA quarterly SGA is now -100.00% below its all-time high of $55.19 million, reached on December 31, 2018.
Performance
AKBA quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$6.68B-$36.48M(-0.55%)Summary
- As of today (September 14, 2025), AKBA TTM SGA is -$6.68 billion, with the most recent change of -$36.48 million (-0.55%) on June 1, 2025.
- Over the past year, AKBA TTM SGA has dropped by -$6.78 billion (-6540.39%).
- AKBA TTM SGA is now -11107.21% below its all-time high of -$59.59 million.
Performance
AKBA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AKBA Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -6540.4% |
| 3 y3 years | -100.0% | -100.0% | -4000.6% |
| 5 y5 years | -100.0% | -100.0% | -4376.0% |
AKBA Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -13.8% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -97.6% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low | <-9999.0% | at low |
AKBA Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $53.73M(-34.0%) |
| Mar 2025 | - | $26.44M(>+9900.0%) | $81.41M(+0.4%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $81.11M(-24.5%) |
| Sep 2024 | - | $27.29M(-1.4%) | $107.40M(+3.6%) |
| Jun 2024 | - | $27.68M(+5.9%) | $103.69M(-0.3%) |
| Mar 2024 | - | $26.15M(-0.5%) | $104.00M(+0.5%) |
| Dec 2023 | $103.47M(-27.0%) | $26.29M(+11.5%) | $103.47M(-4.7%) |
| Sep 2023 | - | $23.57M(-15.8%) | $108.58M(-7.7%) |
| Jun 2023 | - | $27.98M(+9.2%) | $117.64M(-4.2%) |
| Mar 2023 | - | $25.62M(-18.4%) | $122.78M(-13.6%) |
| Dec 2022 | $141.78M(-20.2%) | $31.40M(-3.8%) | $142.18M(-9.2%) |
| Sep 2022 | - | $32.63M(-1.5%) | $156.61M(-8.5%) |
| Jun 2022 | - | $33.13M(-26.4%) | $171.21M(-5.2%) |
| Mar 2022 | - | $45.02M(-1.8%) | $180.62M(+1.7%) |
| Dec 2021 | $177.63M(+12.9%) | $45.83M(-3.0%) | $177.63M(+2.6%) |
| Sep 2021 | - | $47.23M(+11.0%) | $173.09M(+3.8%) |
| Jun 2021 | - | $42.55M(+1.2%) | $166.74M(+3.7%) |
| Mar 2021 | - | $42.02M(+1.8%) | $160.72M(+2.1%) |
| Dec 2020 | $157.36M(+2.9%) | $41.29M(+1.0%) | $157.36M(-2.8%) |
| Sep 2020 | - | $40.88M(+11.9%) | $161.95M(+3.7%) |
| Jun 2020 | - | $36.53M(-5.5%) | $156.18M(-0.3%) |
| Mar 2020 | - | $38.66M(-15.8%) | $156.62M(+2.4%) |
| Dec 2019 | $152.98M(+75.6%) | $45.89M(+30.7%) | $152.98M(-5.7%) |
| Sep 2019 | - | $35.11M(-5.0%) | $162.28M(+18.0%) |
| Jun 2019 | - | $36.96M(+5.5%) | $137.56M(+21.6%) |
| Mar 2019 | - | $35.03M(-36.5%) | $113.13M(+29.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $87.13M(+222.6%) | $55.19M(+431.8%) | $87.13M(+120.5%) |
| Sep 2018 | - | $10.38M(-17.2%) | $39.51M(+10.1%) |
| Jun 2018 | - | $12.54M(+38.9%) | $35.88M(+18.6%) |
| Mar 2018 | - | $9.02M(+19.3%) | $30.24M(+12.0%) |
| Dec 2017 | $27.01M(+21.6%) | $7.57M(+12.1%) | $27.01M(+5.6%) |
| Sep 2017 | - | $6.75M(-2.3%) | $25.59M(+7.6%) |
| Jun 2017 | - | $6.91M(+19.3%) | $23.78M(+7.2%) |
| Mar 2017 | - | $5.79M(-5.8%) | $22.19M(-0.1%) |
| Dec 2016 | $22.21M(+20.1%) | $6.14M(+24.3%) | $22.21M(-5.8%) |
| Sep 2016 | - | $4.94M(-6.9%) | $23.58M(+4.7%) |
| Jun 2016 | - | $5.31M(-8.6%) | $22.52M(+7.7%) |
| Mar 2016 | - | $5.81M(-22.6%) | $20.92M(+13.1%) |
| Dec 2015 | $18.50M(+47.5%) | $7.51M(+93.2%) | $18.50M(+27.3%) |
| Sep 2015 | - | $3.89M(+4.9%) | $14.53M(+7.0%) |
| Jun 2015 | - | $3.71M(+9.3%) | $13.57M(+11.4%) |
| Mar 2015 | - | $3.39M(-4.2%) | $12.18M(-2.9%) |
| Dec 2014 | $12.54M(+143.5%) | $3.54M(+20.5%) | $12.54M(+4.4%) |
| Sep 2014 | - | $2.94M(+26.8%) | $12.01M(+21.7%) |
| Jun 2014 | - | $2.32M(-38.3%) | $9.87M(+20.0%) |
| Mar 2014 | - | $3.75M(+24.6%) | $8.22M(+59.6%) |
| Dec 2013 | $5.15M(+78.2%) | $3.01M(+279.2%) | $5.15M(+49.8%) |
| Sep 2013 | - | $794.00K(+18.9%) | $3.44M(+30.0%) |
| Jun 2013 | - | $667.80K(-1.6%) | $2.64M(+33.8%) |
| Mar 2013 | - | $678.90K(-47.7%) | $1.98M(+52.3%) |
| Dec 2012 | $2.89M(+12.6%) | - | - |
| Dec 2012 | - | $1.30M | $1.30M |
| Dec 2011 | $2.57M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual SGA year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Akebia Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM SGA year-on-year change?
What is Akebia Therapeutics, Inc. annual SGA?
The current annual SGA of AKBA is $0.00
What is the all time high annual SGA for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual SGA is $177.63M
What is Akebia Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, AKBA annual SGA has changed by -$103.47M (-100.00%)
What is Akebia Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of AKBA is $0.00
What is the all time high quarterly SGA for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly SGA is $55.19M
What is Akebia Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, AKBA quarterly SGA has changed by -$27.68M (-100.00%)
What is Akebia Therapeutics, Inc. TTM SGA?
The current TTM SGA of AKBA is -$6.68B
What is the all time high TTM SGA for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM SGA is -$59.59M
What is Akebia Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, AKBA TTM SGA has changed by -$6.78B (-6540.39%)